GENERALIZED ANXIETY DISORDER
Clinical trials for GENERALIZED ANXIETY DISORDER explained in plain language.
Never miss a new study
Get alerted when new GENERALIZED ANXIETY DISORDER trials appear
Sign up with your email to follow new studies for GENERALIZED ANXIETY DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New anxiety pill enters final testing phase
Symptom relief Recruiting nowThis study tests an oral medication called MM120 against a placebo in 250 adults with generalized anxiety disorder. The first 12 weeks are double-blind (neither patients nor doctors know who gets the real drug), followed by a 40-week period where everyone can receive MM120. The m…
Matched conditions: GENERALIZED ANXIETY DISORDER
Phase: PHASE3 • Sponsor: Definium Therapeutics US, Inc. • Aim: Symptom relief
Last updated May 01, 2026 16:01 UTC
-
Can a computer program curb heavy drinking in anxious patients?
Symptom relief Recruiting nowThis study is for people who have both an anxiety disorder and an alcohol use disorder. It tests whether a computer-based therapy can help reduce heavy drinking and improve anxiety symptoms. The program is designed to be easy to access and use, potentially helping many more peopl…
Matched conditions: GENERALIZED ANXIETY DISORDER
Phase: NA • Sponsor: University of Minnesota • Aim: Symptom relief
Last updated May 01, 2026 16:00 UTC
-
New anxiety drug shows promise in chinese trial
Symptom relief Recruiting nowThis study tests a new medicine called crisugabalin for people with generalized anxiety disorder. About 216 adults in China will take either crisugabalin, a placebo, or another anxiety drug (venlafaxine) for 8 weeks. The goal is to see if crisugabalin reduces anxiety symptoms bet…
Matched conditions: GENERALIZED ANXIETY DISORDER
Phase: PHASE2 • Sponsor: Anhui Medical University • Aim: Symptom relief
Last updated May 01, 2026 15:59 UTC
-
New anxiety pill enters final testing phase
Symptom relief Recruiting nowThis study tests an oral medication called MM120 for adults with generalized anxiety disorder. About 200 participants will receive either MM120 or a placebo for 12 weeks, followed by a 40-week period where everyone can receive MM120. The goal is to see if MM120 reduces anxiety sy…
Matched conditions: GENERALIZED ANXIETY DISORDER
Phase: PHASE3 • Sponsor: Definium Therapeutics US, Inc. • Aim: Symptom relief
Last updated May 01, 2026 15:57 UTC
-
New online therapy aims to ease anxiety in teens
Symptom relief Recruiting nowThis study is testing a new internet-based therapy for young people aged 8 to 17 with anxiety disorders. The therapy is a type of talk therapy called cognitive behavioral therapy (CBT) delivered online. The goal is to see if it reduces anxiety and to get feedback from participant…
Matched conditions: GENERALIZED ANXIETY DISORDER
Phase: NA • Sponsor: Lund University • Aim: Symptom relief
Last updated Apr 30, 2026 15:52 UTC
-
Sound waves to soothe anxiety? new trial explores ultrasound therapy
Symptom relief Recruiting nowThis study tests a new, non-invasive treatment for people with generalized anxiety disorder who haven't gotten better with standard medications. The treatment uses low-intensity focused ultrasound to gently stimulate a deep brain area linked to anxiety. Researchers will measure a…
Matched conditions: GENERALIZED ANXIETY DISORDER
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Apr 30, 2026 15:52 UTC
-
New hope for anxiety sufferers? drug trial targets those failed by standard care
Symptom relief Recruiting nowThis study tests an experimental medication called ITI-1284 in adults with generalized anxiety disorder (GAD) who still have symptoms despite trying other treatments. About 570 participants will receive either ITI-1284 or a placebo, added to their usual care. The goal is to see i…
Matched conditions: GENERALIZED ANXIETY DISORDER
Phase: PHASE2 • Sponsor: Intra-Cellular Therapies, Inc. • Aim: Symptom relief
Last updated Apr 29, 2026 15:04 UTC
-
Massage may soothe anxiety by rewiring the brain, new study hopes to prove
Symptom relief Recruiting nowThis study looks at whether Swedish massage or light touch can reduce anxiety symptoms in people with Generalized Anxiety Disorder (GAD). About 46 adults will receive either massage or light touch twice a week for 6 weeks. Researchers will use brain scans (fMRI) and questionnaire…
Matched conditions: GENERALIZED ANXIETY DISORDER
Phase: NA • Sponsor: University of Utah • Aim: Symptom relief
Last updated Apr 29, 2026 15:03 UTC
-
Which anxiety care model works best for kids? new study aims to find out
Symptom relief Recruiting nowThis study compares two approaches to treating anxiety in children and teens aged 8 to 17. In stepped care, everyone starts with internet therapy and gets in-person sessions only if needed. In stratified care, the type of therapy is chosen based on how complex the case is. The go…
Matched conditions: GENERALIZED ANXIETY DISORDER
Phase: NA • Sponsor: Region Skane • Aim: Symptom relief
Last updated Apr 28, 2026 13:12 UTC
-
Breathing test may reveal who Won't benefit from anxiety therapy
Knowledge-focused Recruiting nowThis study is testing whether a simple carbon dioxide (CO2) breathing challenge can help doctors predict which patients with anxiety, OCD, PTSD, or panic disorder will not respond to exposure-based therapy. Researchers will enroll 600 adults aged 18-70 and measure their response …
Matched conditions: GENERALIZED ANXIETY DISORDER
Phase: NA • Sponsor: University of Texas at Austin • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:50 UTC